Paul Aisen

University of Southern California — United States

Medicine · Health Sciences

85h-index32.9kcitations535works8.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dementia and Cognitive Impairment Research(297), Alzheimer's disease research and treatments(174), Health Systems, Economic Evaluations, Quality of Life(100), Functional Brain Connectivity Studies(57), Health, Environment, Cognitive Aging(33)

Publications502 total

Divergent patterns of cognitive decline in preclinical Alzheimer’s disease: implications for secondary prevention trials
2025Open Access
Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 34 Trials including 114,326 Individuals
2025Open Access
Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch
JAMA Neurology·2025Open Access
Blood gene expression network expression strongly relates to brain amyloid burden
Alzheimer s & Dementia·2025· 1 citedOpen Access
Tablet‐based Cognitive Assessment Tool (TabCAT) in a multisite study of early‐onset Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
MRI-based multi-organ clocks for healthy aging and disease assessment
Nature Medicine·2025· 5 citedOpen Access
Brain–heart–eye axis revealed by multi-organ imaging genetics and proteomics
Nature Biomedical Engineering·2025· 4 citedOpen Access
Surface-based morphometry reveals divergent aging trajectories in veterans with and without traumatic brain injury
GeroScience·2025Open Access
Alzheimer's Clinical Research Data via R Packages: the alzverse
arXiv (Cornell University)·2025Open Access
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease
Nature Communications·2025· 4 citedOpen Access
Sleep chart of biological aging clocks in middle and late life
2025Open Access
Amyloid-lowering immunotherapies for Alzheimer disease: current status and future directions
Nature Reviews Neurology·2025· 11 cited
Multi-organ MRI digitizes biological aging clocks across proteomics, metabolomics, and genetics
2025· 1 citedOpen Access
Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study
Translational Psychiatry·2025· 3 citedOpen Access
Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease
JAMA Neurology·2025· 2 cited
Five years of the Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT‐AD)
Alzheimer s & Dementia·2025· 1 citedOpen Access
Advancing the science of recruitment for Alzheimer’s clinical trials: Challenges and opportunities
The Journal of Prevention of Alzheimer s Disease·2025· 1 citedOpen Access
Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid
Neurology·2025· 3 cited
Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease
JAMA Neurology·2025· 26 citedOpen Access
Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force
The Journal of Prevention of Alzheimer s Disease·2025· 10 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

Clifford R. Jack(26), Michael W. Weiner(26), Michael Donohue(22), William J. Jagust(20), Ronald G. Thomas(18), Laurel Beckett(17), John C. Morris(17), Ronald C. Petersen(16), Arthur W. Toga(16), Andrew J. Saykin(16), Robert C. Green(14), Leslie M. Shaw(13), Anthony Gamst(11), John Q. Trojanowki(10), John Q. Trojanowski(9), Matt A. Bernstein(9), Ronald Petersen(9), Reisa A. Sperling(8), Robert A. Koeppe(8), Rachelle S. Doody(8)